<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01047176</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-CRU-CRE-2009/1</org_study_id>
    <nct_id>NCT01047176</nct_id>
  </id_info>
  <brief_title>Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take Statins</brief_title>
  <acronym>OPTIMA</acronym>
  <official_title>Observational Prospective Study to esTIMAte the Rates of Outcomes in Patients Undergoing PCI With Drug Eluting Stent (DES) Implantation Who Take Statins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To estimate the rates of percutaneous coronary intervention (PCI) outcomes in patients after
      drug-eluting stents implantation who take statins.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To estimate the rates of percutaneous coronary intervention (PCI) outcomes in patients after drug-eluting stents implantation who take statins.</measure>
    <time_frame>3 visits for 12 month (before and after PCI)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate prognostic factors (demographic, co-morbidity, smoking, LDL-C, inflammatory and cardiac markers) in patients undergoing PCI with drug eluting stent (DES) implantation who take statins and their association with PCI (MACCE) outcomes</measure>
    <time_frame>3 visits for 12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To estimate Low Density Lipoprotein Cholesterol (LDL-C) target level achievement and lipid-lowering therapy details in patients taking standard lipid lowering therapy prior the PCI.</measure>
    <time_frame>3 visits for 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To estimate inflammatory markers (C-reactive protein (CRP) and Leukocytes) in patients prior and after PCI.</measure>
    <time_frame>3 visits for 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To estimate cardiac markers (Troponin I, brain natriuretic peptide (BNP)) in patients before PCI.</measure>
    <time_frame>3 visits for 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To study lipoprotein associated phospholipase A2 (Lp PLA2) in patients before PCI and its' association with PCI outcome.</measure>
    <time_frame>3 visits for 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To study the rate of early and late stent thrombosis according to ARC classification</measure>
    <time_frame>3 visits for 12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">602</enrollment>
  <condition>Dyslipidemia</condition>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Male or female &gt; 18 year of age with indication to PCI</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Hospital patient
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable angina with indication to PCI

          -  Hospitalization to Russian Cardiological Research Center (РКНПК) for PCI procedure
             with drug-eluting stents implantation

          -  Statin therapy initiated for at least one month prior to PCI

          -  Written informed consent provided prior the start of participation in the study.

        Exclusion Criteria:

          -  Subjects who are unwilling or unable to provide informed consent.

          -  Presence of ACS during the current hospitalization

          -  Severe CHF (NYHA III/IV) or LVEF&lt;40 %

          -  Stroke within 6 months before PCI

          -  Acute or chronic inflammatory disease

          -  Anti-inflammatory medications intake, with the exception of aspirin

          -  Severe liver or muscle disease

          -  Severe kidney disease / renal failure with creatinine &gt; 3 mg/dl

          -  History of oncologic disease

          -  Conceivable impossibility to come in touch with the patient or his family at 1-year
             after the intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuri A Karpov</last_name>
    <role>Principal Investigator</role>
    <affiliation>RCRC (РКНПК)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2010</study_first_submitted>
  <study_first_submitted_qc>January 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2010</study_first_posted>
  <last_update_submitted>February 29, 2012</last_update_submitted>
  <last_update_submitted_qc>February 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 1, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Statins</keyword>
  <keyword>Coronary Heart Disease</keyword>
  <keyword>Percutaneous coronary intervention (PCI)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

